Network origin in Mary Jenkins first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mary Jenkins via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Corporate Secretary | |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| BAXALTA INC | Biotechnology | President | |
Shire US, Inc.
 Shire US, Inc. Medical DistributorsDistribution Services Shire US, Inc. sells and markets prescription medicines. The company was founded on September 28, 1983 and is headquartered in Lexington, MA. | Medical Distributors | Director/Board Member President | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Director/Board Member | |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Franklin Pierce University | College/University | Undergraduate Degree | |
Lotus Tissue Repair, Inc.
 Lotus Tissue Repair, Inc. Pharmaceuticals: MajorHealth Technology Lotus Tissue Repair, Inc. develops dermatologic treatment technologies. Its solutions include a protein replacement therapy for the treatment of dystrophic epidermolysis bullosa, a group of genetic skin disease. The company was founded by Mei Chen, Mark P. de Souza, Philip R. Reilly, David Woodley and James W. Fordyce in 2011 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 11 |
Sectoral
| Health Technology | 9 |
| Distribution Services | 2 |
| Consumer Services | 2 |
Operational
| Director/Board Member | 7 |
| Corporate Secretary | 6 |
| President | 3 |
| Treasurer | 2 |
| Director of Finance/CFO | 2 |
Most connected contacts
| Insiders | |
|---|---|
| Colleen Tupper | 7 |
| Jason E. Baranski | 6 |
- Stock Market
- Insiders
- Mary Jenkins
- Company connections